生存素下调多药耐药蛋白增强人鼻咽癌细胞株对紫杉醇敏感性的研究
时间:2022-04-14 08:10:13 浏览次数:次
杨 宁1 朱乐攀2 谭 潭2 侯春燕1
1.湖南省郴州市第一人民医院耳鼻喉科,湖南郴州 423000;
2.湖南省郴州市第一人民医院检验科,湖南郴州 423000
[摘要] 目的 研究生存素(Survivin)下调多药耐药蛋白(MRP)的表达与鼻咽癌紫杉醇(PTX)耐药性关系,探讨鼻咽癌PTX耐药的分子机制。 方法 采用免疫组化检测Survivin和MRP在42例鼻咽癌PTX耐药患者与24例PTX非耐药患者中的表达;采用浓度递增法持续诱导建立鼻咽癌化疗耐药细胞株5-8F-PTX(+),绘制细胞生长曲线,测定细胞生长的倍增时间,检测肿瘤细胞的周期分布;采用siRNA技术干扰5-8F-PTX(+)中Survivin的表达后,Western blot法检测Survivin和MRP表达变化,MTT检测不同抗肿瘤药物PTX、顺铂(cDDP)、5-氟尿嘧啶(5-FU)、长春新碱(VCR)耐药敏感性的变化。 结果 Survivin在鼻咽癌化疗耐药患者中阳性表达率为83.3%,明显高于非耐药患者(41.7%),差异有高度统计学意义(P < 0.01);MRP在鼻咽癌PTX耐药患者中表达阳性率为88.1%,明显高于非耐药患者(37.5%),差异有高度统计学意义(P < 0.01)。5-8F-PTX(+)较5-8F的细胞生长速度明显减慢,5-8F-PTX(+)细胞生长的倍增时间为21 h,亲本5-8F细胞生长的倍增时间为15 h;5-8F-PTX(+)的G2/M期细胞百分比[(23.1±1.3)%]显著高于亲本5-8F细胞[(13.5±0.9)%];Survivin和MRP在PTX耐药细胞株5-8F-PTX(+)细胞株中的表达水平明显高于非耐药的5-8F,siRNA干扰5-8F-PTX(+)中Survivin的表达后,Survivin和MRP表达明显下调,PTX、cDDP、5-FU、VCR耐在siRNA-5-8F-PTX(+)中的IC50值不同程度地下降。 结论 Survivin可通过下调MRP的表达增强鼻咽癌细胞对PTX的敏感性。
[关键词] 鼻咽癌;紫杉醇;耐药性;生存素;多药耐药相关蛋白
[中图分类号] R739 [文献标识码] A [文章编号] 1673-7210(2014)03(b)-0009-06
The study of Survivin increase drug sensitivity to Paclitaxel in human nasopharyngeal carcinoma cell line by down regulate MRP expression
YANG Ning1 ZHU Lepan2 TAN Tan2 HOU Chunyan1
1.Department of ENT, the First People"s Hospital of Chenzhou City, Hu"nan Province, Chenzhou 423000, China; 2.Department of Inspection, the First People"s Hospital of Chenzhou City, Hu"nan Province, Chenzhou 423000, China
[Abstract] Objective To find the relationship among Survivin and multidrug resistance associated protein (MRP) and drug resistance in nasopharyngeal carcinoma (NPC), and to explore the mechanism of drug resitance to Paclitaxel (PTX) in NPC. Methods Expression of Survivin and MRP were detected by immunohistochemistry method in 42 cases of NPC patients with Paclitaxel resistance and 24 cases of NPC patients without Paclitaxel resistance. The Paclitaxel resistance cell line, 5-8F-PTX (+) was established by a step-increased method. The curve of growth were drew and the doubling time were detected, and the distribution of cell cycle were detected by flow cytometry in 5-8F-PTX (+) and 5-8F. The expression of Survivin and MRP were detected by western blot after siRNA to 5-8F-PTX (+), the drug sensitivity of various kinds of antitumor drug, such as Paclitaxel, cDDP, 5-FU and Vincristine were detected by MTT method. Results The positive of survivin were 83.3% in NPC patients with Paclitaxel resistance and significant high than that of NPC patients without Paclitaxel resistance (41.7%), the difference was highly statistically significant (P < 0.01); the positive of MRP was 88.1% in NPC patients with Paclitaxel resistance and significant high than that of NPC patients without Paclitaxel resistance (37.5%), the difference was highly statistically significant (P < 0.01). The growth velocity decreased more obviously in 5-8F-PTX (+) than 5-8F, and the doubling time were 21 h in 5-8F-PTX (+) and 15 h in parent 5-8F. The ratio of G2/M cell cycle [(23.1±1.3)%] in 5-8F-PTX (+) was higher than that in 5-8F [(13.5±0.9)%]. The expression of Survivin and MRP were higher in 5-8F-PTX (+) than those in 5-8F. After siRNA treatment, expression of Survivin and MRP were obviously down regulated in siRNA-5-8F-PTX (+) than 5-8F-PTX (+) and 5-8F-PTX (+)-empty vector. The IC50 of Paclitaxel, cDDP, 5-FU and Vincristine were significantly down regulated in siRNA-5-8F-PTX (+) than 5-8F-PTX (+). Conclusion Decreasing of survivin expression can down regulate the expression of MRP and result into increase of drug sensitivity to Paclitaxel in NPC.
推荐访问: 细胞株 紫杉醇 鼻咽癌 耐药 敏感性[生存素下调多药耐药蛋白增强人鼻咽癌细胞株对紫杉醇敏感性的研究]相关文章
- miR936对人喉癌细胞株Hep2增殖、迁移、侵袭和药物敏感性的影响
- 甘草甜素诱导前列腺癌细胞株DU145凋亡的体外研究
- 小檗碱对Aβ2535致SHSY5Y细胞株炎症反应中TNFα及I型受体表达的干预作用
- 多西紫杉醇与顺铂同步化疗联合放疗治疗食管癌的疗效评价
- 紫杉醇脂质体治疗晚期食管癌的效果
- 多西紫杉醇联合替吉奥治疗蒽环类耐药晚期乳腺癌的临床分析
- 紫杉醇联合顺铂化疗用于晚期食道癌治疗中的效果观察
- 紫杉醇关键酶基因TwDBAT在平菇中的遗传转化及表达
- 二甲双胍联合紫杉醇诱导人乳腺癌细胞MCF—7凋亡的作用机制研究
- 鼻咽癌放疗期间口腔黏膜真菌感染分析及治疗
- 局部晚期鼻咽癌同期放化疗的护理干预效果观察
- 调强放疗联合同期化疗治疗局部晚期鼻咽癌的疗效观察
- 鼻咽癌立体定位适形放疗疗效及影响因素分析
- Ki67\nm23基因在鼻咽癌中的表达及其意义
- SEMA3B基因在鼻咽癌组织中的表达、杂合性丢失和甲基化分析
- PCNA和CD44v6在鼻咽癌组织中的表达及其相互关系
- 金黄色葡萄球菌在我院医院感染中的临床分布及耐药性研究
- 卡他莫拉菌快速鉴定及耐药性分析
- 1603株肺炎克雷伯菌感染特性及耐药性分析
- 加强细菌耐药性的控制
- 鲍曼不动杆菌碳青霉烯酶耐药基因分析及同源性研究
- COPD合并支气管扩张病原体流行病学及耐药性研究进展
- 儿童耐药肺炎克雷伯杆菌研究进展
- 临床药师参与1例多重耐药鲍曼不动杆菌感染的病例分析
- 大肠埃希菌耐药性检测及临床意义
- 重症医学科鲍曼不动杆菌分布及耐药性研究